Loading...
Selecta Biosciences Inc.

Selecta Biosciences Inc. (SELB)

1.41
0 (0.00%)

About


Werner Cautreels
Healthcare
Biotechnology
NASDAQ Global Market

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover & develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.